RxDoctor Payments Data

Deborah Ibarra

Psychiatric/Mental Health · Doral, FLNPI 1407359946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,778, 3.0 times the $939 reported in 2023. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,970in general payments, 2019–2025

Across 248 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$860
  • Axsome Therapeutics, Inc.$843
  • Johnson & Johnson$628
  • AbbVie$584
  • Otsuka America Pharmaceutical, Inc.$260
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$5,970100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,970 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl42$54,185
Vilazodone Hcl21$2,155
Eszopiclone12$259
Trazodone Hcl23$114
Quetiapine Fumarate16$100
Clonazepam21$71
Sertraline Hcl27$68
Escitalopram Oxalate17$63
Alprazolam30$31

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$628$54,18542 claims
Almatica Pharma LLCSertraline Hcl$201$6827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Doral

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →